genomichealth.com Report : Visit Site

Technical data of the genomichealth.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host genomichealth.com. Currently, hosted in United States and its service provider is UltraDNS Corp .

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Microsoft-IIS/8.5 containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

i agree genomic health does not give treatment for cancer or advise patients on their treatment plans. anyone in doubt about their own health or cancer should seek medical advice from a qualified healthcare professional. placeholder toggle navigation ✖ menu who we are what we do oncotype iq products who we help join our team investors newsroom resources portal login who we are back overview our mission company timeline & milestones leadership our founders contact us what we do back overview clinical leadership world class commercial channel patient advocacy oncotype iq products back overview oncotype dx oncotype dx for breast cancer oncotype dx for prostate cancer oncotype dx for colon cancer our product pipeline who we help back overview join our team back overview u.s. benefits international benefits united states - english back united states - english deutschland - deutsch france - français italia - italiano japan - japanese united kingdom - english investors newsroom resources portal login united states - english deutschland - deutsch france - français italia - italiano japan - japanese united kingdom - english toggle navigation who we are what we do oncotype iq products who we help join our team genomic health is the world's leading provider of genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer, one of the greatest issues in healthcare today. learn more overview our mission company timeline & milestones leadership our founders contact us genomic health and oncotype iq – delivering precision medicine watch how genomic health continues to transform cancer care around the world. watch video it is our mission to transform treatment decisions and outcomes in cancer by delivering clinically actionable diagnostics and services for patients. learn more overview clinical leadership world class commercial channel patient advocacy individual molecular fingerprint of tumors kim popovits discusses devising personalized medicine in the treatment of breast cancer and colon cancer. watch video our portfolio of tests is aimed at delivering genomic intelligence that optimizes treatment decisions throughout the cancer patient journey. learn more overview oncotype dx oncotype dx for breast cancer oncotype dx for prostate cancer oncotype dx for colon cancer our product pipeline not all breast cancer is the same. get your oncotype dx score. hear how breast cancer survivors personalized their cancer treatment with oncotype dx. watch video genomic health is driven by the commitment to improving the lives of cancer patients. learn more overview your prostate your decision: interview with dan dan was diagnosed with early-stage prostate cancer. watch dan talk about his experience with the oncotype dx prostate cancer test. watch video inspired by the life, changing work that we do? be a part of the world's leading provider of genomic cancer diagnostic tests. learn more overview u.s. benefits international benefits the genomic health brand and company mission watch ceo kim popovits and others discuss the motivation, inspiration, and rewards of working at genomic health, as well as the company’s vision for the future. watch video toggle search ✖ life, changing. more than 900,000 cancer patients worldwide have used our oncotype dx tests to personalize treatments and improve outcomes. our mission genomic health’s mission is to transform treatment decisions and outcomes in cancer by delivering clinically actionable diagnostics and services. read more oncotype iq our portfolio of tests and services is aimed at delivering genomic intelligence that optimizes treatment decisions and outcomes throughout the cancer patient journey. read more landmark tailorx results the results demonstrate that the oncotype dx breast recurrence score test definitively identifies the 70% of women with early-stage breast cancer who receive no benefit from chemotherapy, and the 30% of women for whom chemotherapy benefit can be life-saving. learn more making an impact genomic health is leading in the precision medicine revolution to eliminate the "one-size-fits-all" approach to cancer treatment. our pipeline developing liquid- and tissue-based genomic tests that address critical treatment questions throughout all stages of cancer. learn more tailorx: transforming the treatment of breast cancer landmark tailorx results demonstrate that the oncotype dx breast recurrence score test definitively identifies the 70% of women with early-stage breast cancer who receive no benefit from chemotherapy, and the 30% of women for whom chemotherapy benefit can be life-saving. watch video world class commercial channel we deliver over 400 oncotype dx test results per day to more than 90 countries through our centralized clinical laboratory, serving physicians and patients with our industry-leading customer service team and more than 200 sales and managed care representatives around the world. learn more broadening reimbursement for patients worldwide genomic health is dedicated to securing reimbursement to ensure cancer patients around the world have access to our clinically actionable oncotype dx tests. outside the u.s., there are over 260 million lives covered and growing. the oncotype dx prostate cancer test is now covered by medicare in the u.s. for qualified patients, giving nearly 60,000 prostate cancer patients the opportunity to personalize their cancer treatment. learn more unsurpassed scientific and clinical expertise our expertise consistently demonstrates to physicians, patients and payors that our tests are improving treatment decisions and outcomes, providing significant benefit from both a care and cost perspective. learn more “genomic testing helped me make my decision. i would advise anybody to get all the information you can before you make a decision about your life and your body.” jim g. read more our people genomic health employees on the gratification of their jobs genomic health employees on the company's higher purpose previous next who we are our mission timeline & milestones leadership contact us who we help what we do clinical leadership commercial channel patient advocacy join our team careers u.s. benefits international benefits oncotype iq products oncotype dx for breast cancer for prostate cancer for colon cancer our product pipeline newsroom press releases media resources social hub in the news investors resources videos patient resources publications & guidelines abstracts grants & contributions glossary licenses & accreditations privacy policy terms & conditions licenses & accreditations privacy policy terms & conditions © 2018 genomic health, all rights reserved. © 2018 genomic health, all rights reserved. in the us and certain other jurisdictions, genomic health, oncotype dx, oncotype iq, and recurrence score are registered trademarks, and genomic prostate score, and ar-v7 nucleus detect are pending registered trademarks, of genomic health, inc. © 2018 genomic health, all rights reserved. in the us and certain other jurisdictions, genomic health, oncotype dx, oncotype iq, and recurrence score are registered trademarks, and genomic prostate score, and ar-v7 nucleus detect are pending registered trademarks, of genomic health, inc.

URL analysis for genomichealth.com

http://www.genomichealth.com/oncotype_iq_products
http://www.genomichealth.com/what_we_do/clinical_leadership
http://www.genomichealth.com/resources/abstracts
http://www.genomichealth.com/terms_and_conditions
http://www.genomichealth.com/who_we_are/contact_us
http://www.genomichealth.com/who_we_are/our_founders
http://www.genomichealth.com/what_we_do
http://www.genomichealth.com/resources
http://www.genomichealth.com/join_our_team/international_benefits
http://www.genomichealth.com/resources/
http://www.genomichealth.com/oncotype_iq_products/our_pipeline
http://www.genomichealth.com/resources/publications_and_treatment_practice_guidelines
http://www.genomichealth.com/join_our_team
http://www.genomichealth.com/en-us/advocacy
http://www.genomichealth.com/advocacy

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: GENOMICHEALTH.COM
Registry Domain ID: 31532583_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.register.com
Registrar URL: http://www.register.com
Updated Date: 2018-06-05T20:10:08Z
Creation Date: 2000-07-18T14:19:34Z
Registry Expiry Date: 2027-07-18T14:19:34Z
Registrar: Register.com, Inc.
Registrar IANA ID: 9
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: UDNS1.ULTRADNS.NET
Name Server: UDNS2.ULTRADNS.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-06-24T09:42:38Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR Register.com, Inc.

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =genomichealth.com

  PORT 43

  TYPE domain

DOMAIN

  NAME genomichealth.com

  CHANGED 2018-06-05

  CREATED 2000-07-18

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited

NSERVER

  UDNS1.ULTRADNS.NET 204.69.234.1

  UDNS2.ULTRADNS.NET 204.74.101.1

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .